N-(5-(3,5-Dicyano-1,2,6-trimethyl-1,4-dihydropyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl)-2-ethylbenzamide
98%
science Other reagents with same CAS 2377576-35-5
blur_circular Chemical Specifications
description Product Description
Used in pharmaceutical research as a potent inhibitor of cyclin-dependent kinases (CDKs), particularly CDK2 and CDK9, making it a candidate for anticancer drug development. It shows promise in disrupting cell cycle progression and transcription in tumor cells, especially in hematological malignancies. Its structure enables high selectivity and improved metabolic stability, supporting its evaluation in preclinical studies for targeted cancer therapies.
shopping_cart Available Sizes & Pricing
Cart
No products